Literature DB >> 33515286

Complete genome sequence of lovastatin producer Aspergillus terreus ATCC 20542 and evaluation of genomic diversity among A. terreus strains.

Małgorzata Ryngajłło1, Tomasz Boruta2, Marcin Bizukojć2.   

Abstract

In the present study, the complete genome of a filamentous fungus Aspergillus terreus ATCC 20542 was sequenced, assembled, and annotated. This strain is mainly recognized for being a model wild-type lovastatin producer and a parental strain of high-yielding industrial mutants. It is also a microorganism with a rich repertoire of secondary metabolites that has been a subject of numerous bioprocess-related studies. In terms of continuity, the genomic sequence provided in this work is of the highest quality among all the publicly available genomes of A. terreus strains. The comparative analysis revealed considerable diversity with regard to the catalog of biosynthetic gene clusters found in A. terreus. Even though the cluster of lovastatin biosynthesis was found to be well-conserved at the species level, several unique genes putatively associated with metabolic functions were detected in A. terreus ATCC 20542 that were not detected in other investigated genomes. The analysis was conducted also in the context of the primary metabolic pathways (sugar catabolism, biomass degradation potential, organic acid production), where the visible differences in gene copy numbers were detected. However, the species-level genomic diversity of A. terreus was more evident for secondary metabolism than for the well-conserved primary metabolic pathways. The newly sequenced genome of A. terreus ATCC 20542 was found to harbor several unique sequences, which can be regarded as interesting subjects for future experimental efforts on A. terreus metabolism and fungal biosynthetic capabilities. KEY POINTS: • The high-quality genome of Aspergillus terreus ATCC 20542 has been assembled and annotated. • Comparative analysis with other sequenced Aspergillus terreus strains has revealed considerable diversity in biosynthetic gene repertoire, especially related to secondary metabolism. • The unique genomic features of A. terreus ATCC 20542 are discussed.

Entities:  

Keywords:  Aspergillus terreus; Comparative genomics; Genome; Secondary metabolites

Mesh:

Substances:

Year:  2021        PMID: 33515286      PMCID: PMC7880949          DOI: 10.1007/s00253-021-11133-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  39 in total

1.  Culture-based and sequence-based insights into biosynthesis of secondary metabolites by Aspergillus terreus ATCC 20542.

Authors:  Tomasz Boruta; Marcin Bizukojc
Journal:  J Biotechnol       Date:  2014-02-15       Impact factor: 3.307

2.  tRNAscan-SE: Searching for tRNA Genes in Genomic Sequences.

Authors:  Patricia P Chan; Todd M Lowe
Journal:  Methods Mol Biol       Date:  2019

3.  [T-cell immunity in syphilis patients].

Authors:  L A Manuĭlova; V P Fedotov; V P Logunov
Journal:  Vestn Dermatol Venerol       Date:  1983-03

4.  SignalP 5.0 improves signal peptide predictions using deep neural networks.

Authors:  José Juan Almagro Armenteros; Konstantinos D Tsirigos; Casper Kaae Sønderby; Thomas Nordahl Petersen; Ole Winther; Søren Brunak; Gunnar von Heijne; Henrik Nielsen
Journal:  Nat Biotechnol       Date:  2019-02-18       Impact factor: 54.908

5.  Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains.

Authors:  Manor Askenazi; Edward M Driggers; Douglas A Holtzman; Thea C Norman; Sara Iverson; Daniel P Zimmer; Mary-Ellen Boers; Paul R Blomquist; Eduardo J Martinez; Alex W Monreal; Toby P Feibelman; Maria E Mayorga; Mary E Maxon; Kristie Sykes; Jenny Vittum Tobin; Etchell Cordero; Sofie R Salama; Joshua Trueheart; John C Royer; Kevin T Madden
Journal:  Nat Biotechnol       Date:  2003-01-21       Impact factor: 54.908

Review 6.  Biotechnological production and applications of statins.

Authors:  Javier Barrios-González; Roxana U Miranda
Journal:  Appl Microbiol Biotechnol       Date:  2009-10-10       Impact factor: 4.813

7.  Simultaneous biosynthesis of (+)-geodin by a lovastatin-producing fungus Aspergillus terreus.

Authors:  Marcin Bizukojc; Stanislaw Ledakowicz
Journal:  J Biotechnol       Date:  2007-07-10       Impact factor: 3.307

8.  Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Authors:  A W Alberts; J Chen; G Kuron; V Hunt; J Huff; C Hoffman; J Rothrock; M Lopez; H Joshua; E Harris; A Patchett; R Monaghan; S Currie; E Stapley; G Albers-Schonberg; O Hensens; J Hirshfield; K Hoogsteen; J Liesch; J Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Induction of secondary metabolism of Aspergillus terreus ATCC 20542 in the batch bioreactor cultures.

Authors:  Tomasz Boruta; Marcin Bizukojc
Journal:  Appl Microbiol Biotechnol       Date:  2015-11-25       Impact factor: 4.813

10.  Invasive Aspergillus terreus morphological transitions and immunoadaptations mediating antifungal resistance.

Authors:  Louis Bengyella; Elsie Laban Yekwa; Muhammad Nasir Subhani; Ernest Tambo; Kiran Nawaz; Bakoena Ashton Hetsa; Sehrish Iftikhar; Sayanika Devi Waikhom; Pranab Roy
Journal:  Infect Drug Resist       Date:  2017-11-07       Impact factor: 4.003

View more
  2 in total

1.  High molecular weight DNA extraction methods lead to high quality filamentous ascomycete fungal genome assemblies using Oxford Nanopore sequencing.

Authors:  Celine Petersen; Trine Sørensen; Klaus R Westphal; Lavinia I Fechete; Teis E Sondergaard; Jens L Sørensen; Kåre L Nielsen
Journal:  Microb Genom       Date:  2022-04

2.  Bioprocessing of Two Crop Residues for Animal Feeding into a High-Yield Lovastatin Feed Supplement.

Authors:  Amaury Ábrego-García; Héctor M Poggi-Varaldo; M Teresa Ponce-Noyola; Graciano Calva-Calva; Cutberto José Juvencio Galíndez-Mayer; Gustavo G Medina-Mendoza; Noemí F Rinderknecht-Seijas
Journal:  Animals (Basel)       Date:  2022-10-07       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.